Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Innovation

Innovation

JLABS @ Washington, DC: The unique innovation hub that’s poised to help protect us from future pandemics

Scientists at the facility, opening in the nation’s capital this year, will be focused on advancing breakthrough ideas for safeguarding people around the world from pandemics like COVID-19, infectious diseases and other health threats.

Chairman and CEO Alex Gorsky profiled by the Financial Times about Johnson & Johnson’s work on a potential COVID-19 vaccine

The article explores what guided the decision, which is just the latest example of our Chairman and CEO’s people-first approach to leadership at our healthcare company.

“I’m a scientist working on a potential COVID-19 vaccine”: Meet a researcher who’s studying a promising candidate

Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.

“I have never seen a moment so rich in collaboration, ingenuity and acts of bravery": Johnson & Johnson announces it has identified a lead COVID-19 vaccine candidate

Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.

What it really feels like to have multiple sclerosis

The exact cause of the disease is unknown, but there’s a lot scientists do know about how it impacts nearly every part of the body. Scientists like Tatiana Scherz, M.D., who takes us on a guided journey of how the disease manifests—from your brain down to your toes.

Can an Apple Watch reduce the likelihood of suffering a stroke? The innovative study that’s tackling the problem of AFib

Cardiologist C. Michael Gibson is heading up a virtual research study that uses wearable technology and cutting-edge apps to help detect atrial fibrillation, one of the biggest risk factors for stroke. We dive into how the study will work.

Could the answer to preventing hospital-acquired pneumonia be as simple as better oral care? This nurse thinks so.

Some 157,000 patients are diagnosed with the condition each year. But trailblazing nurse Dian Baker has a straightforward yet innovative solution.

An expert explains the latest good—yes, good!—news about lung cancer

A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what’s to come in better detecting and preventing it.

That’s so presidential! 4 of Johnson & Johnson’s most memorable moments with heads of state

In honor of Presidents’ Day, the company’s chief historian shares some stories of special company connections to former U.S. presidents, including the day one leader awarded Johnson & Johnson with a medal for a century’s worth of innovation.

What you need to know about the coronavirus—and a potential preventive vaccine

The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.